Home LiteratureArticle Details
PMID: 178674 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Increased susceptibility of murine teratocarcinoma cells to Simian virus 40 and polyoma virus following treatment with 5-bromodeoxyuridine.

Journal of cellular physiology ·Vol. 88 ·No. 3 ·1976-07-00 ·Pages 297-305

Speers WC, Lehman JM

Abstract

Cultures of the multipotential stem cell, embryonal carcinoma (EC), of a murine teratocarcinoma were treated with 5-bromodeoxyuridine (BrdU). Within 2-4 days at concentrations of 1-50 mugm/ml of BrdU, there was a marked change in the morphology of cells observed by light and electron microscopy. A comparison of the growth potential showed that for up to four days the BrdU-treated cultures were similar to untreated cultures. When these BrdU-treated cells were infected with Simian virus 40 (SV40) and polyoma virus (Py), there was an increase in susceptibility of the treated cells. The untreated embryonal carcinoma cells were refractory. These results suggest that BrdU modifies the embryonal carcinoma cells to allow infection with two DNA viruses.

MeSH Terms
Antigens, Viral/analysis Bromodeoxyuridine/pharmacology Cell Division Cell Line Cell Nucleus/ultrastructure Cytopathogenic Effect, Viral/drug effects Dose-Response Relationship, Drug Endoplasmic Reticulum/ultrastructure Floxuridine/pharmacology Mitochondria/ultrastructure Polyomavirus Ribosomes/ultrastructure Simian virus 40
Chemicals
Antigens, Viral Floxuridine Bromodeoxyuridine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Speers W C
Lehman J M
Article Info
Journal
Journal of cellular physiology
Abbr.
J Cell Physiol
ISSN
0021-9541
Published
1976-07-00
Pages
297-305
Language
English
Region
United States
NLM ID
0050222
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com